Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Lancashire flags possibility of further disasters after tough year

(Sharecast News) - Lancashire Holdings reported a profit after tax of $321.3m in its 2024 final results on Thursday, and a 23.4% increase in diluted book value per share. The FTSE 250 company said gross premiums written rose 11.3% to $2.15m, while insurance revenue increased 16.1% to $1.77m.

It said it achieved an insurance service result of $379.9m, with a combined ratio of 89.1% on an undiscounted basis and 80.0% when discounted.

The investment portfolio contributed to results with a total return of 5%, supporting Lancashire's overall profitability.

Lancashire declared total dividends of $294.3m for the year, including a final ordinary dividend of 15 cents per share and a special dividend of 25 cents per share, subject to shareholder approval.

In total, capital returns to investors amounted to $354.2m in 2024.

Lancashire said it continued to expand its underwriting portfolio, more than doubling the number of product classes since 2018 to capture growth opportunities.

Despite a year of high industry losses, the company maintained strong underwriting discipline.

Net losses from catastrophe and large risk events, including hurricanes Milton, Helene, and Debby, storm Boris, and the Calgary hailstorms, totaled $214.1m.

The most significant large risk event was the MV Dali Baltimore bridge collision.

Looking ahead, Lancashire said it remained well-capitalised to fund future growth.

Early in 2025, the company announced expected losses of $145m to $165m from the California wildfires.

Assuming a similar level of catastrophe and large losses as in 2024, Lancashire anticipated delivering a mid-teens return on equity for 2025, reinforcing its strategy of providing more predictable investor returns.

The company noted that it was marking its 20th anniversary this year, adding that it remained focused on further growth in a market where demand for its specialised reinsurance solutions remains resilient.

"2024 was another superb year for Lancashire with an excellent profit after tax of $321.3m delivering a strong return on equity of 23.4%," said chief executive officer Alex Maloney.

"In a year of high industry losses this is an outstanding result. It shows the continued successful execution of our strategy to grow materially at the right time in the underwriting cycle, utilise our capital more efficiently, diversify our portfolio to reduce volatility, and retain and attract the best talent.

"Throughout 2024, we continued to take advantage of the healthy margin environment. Gross premiums written increased by 11.3% to more than $2.1bn and insurance revenue was $1.7bn, an increase of 16.1% on 2023."

Maloney said that as a result, the company delivered an "excellent" underwriting return, with an insurance service result of $379.9m, and a combined ratio of 89.1%, underpinned by Lancashire's "robust and disciplined" underwriting approach.

"Early in 2025, we have seen the terrible devastation wrought by the wildfires in California on those communities.

"As recently announced, for Lancashire, the impact is expected to be within the range $145m to $165m."

With a similar level of catastrophe and large losses as 2024, in addition to the wildfire loss, Maloney said Lancashire would anticipate delivering a return on equity in the mid-teens in 2025.

"Whilst this assumes a significantly above average loss environment, our guidance clearly demonstrates the continued delivery of our strategy of more predictable returns for investors."

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.